FDA greenlights Eli Lilly COVID-19 combo therapy
February 11 2021, 08:00
The Food and Drug Administration (FDA) has issued emergency approval to an antibody drug combo treatment from Eli Lilly for high-risk patients recently diagnosed with coronavirus disease.
The Food and Drug Administration (FDA) has issued emergency approval to an antibody drug combo treatment from Eli Lilly for high-risk patients recently diagnosed with coronavirus disease.
Source:
FOX News